Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman

Bladder cancer is the fourth most common malignancy in men and ninth most in woman. Most bladder cancers are urothelial, and the neuroendocrine sub-types make up 0.5–1.0% of cases. Here we present a 70-year-old female with poorly differentiated small cell carcinoma of the bladder who complains of an...

Full description

Bibliographic Details
Main Authors: Jordan Sarver, Mark Memo
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Urology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442021003636
_version_ 1818402349897482240
author Jordan Sarver
Mark Memo
author_facet Jordan Sarver
Mark Memo
author_sort Jordan Sarver
collection DOAJ
description Bladder cancer is the fourth most common malignancy in men and ninth most in woman. Most bladder cancers are urothelial, and the neuroendocrine sub-types make up 0.5–1.0% of cases. Here we present a 70-year-old female with poorly differentiated small cell carcinoma of the bladder who complains of an extensive history of gross hematuria. She was started on a neoadjuvant chemotherapy regimen of 21-day Etoposide with Carboplatin and radical cystectomy. More work needs to be done when it comes to the best treatment method for this rare cohort of patients.
first_indexed 2024-12-14T08:06:57Z
format Article
id doaj.art-9173892fb9254811a7d63b248996f0ca
institution Directory Open Access Journal
issn 2214-4420
language English
last_indexed 2024-12-14T08:06:57Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Urology Case Reports
spelling doaj.art-9173892fb9254811a7d63b248996f0ca2022-12-21T23:10:08ZengElsevierUrology Case Reports2214-44202022-01-0140101923Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk womanJordan Sarver0Mark Memo1Ohio University Heritage College of Osteopathic Medicine, Athens, OH, 45701, United States; Corresponding author. Ohio University College of Osteopathic Medicine, 191 W Union St, Athens, OH, 45701, United States.NEOurology, 7430 Southern Blvd, Boardman, OH, 44512, United StatesBladder cancer is the fourth most common malignancy in men and ninth most in woman. Most bladder cancers are urothelial, and the neuroendocrine sub-types make up 0.5–1.0% of cases. Here we present a 70-year-old female with poorly differentiated small cell carcinoma of the bladder who complains of an extensive history of gross hematuria. She was started on a neoadjuvant chemotherapy regimen of 21-day Etoposide with Carboplatin and radical cystectomy. More work needs to be done when it comes to the best treatment method for this rare cohort of patients.http://www.sciencedirect.com/science/article/pii/S2214442021003636Bladder cancerNeuroendocrine tumorOncologyNeoadjuvant chemotherapy
spellingShingle Jordan Sarver
Mark Memo
Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
Urology Case Reports
Bladder cancer
Neuroendocrine tumor
Oncology
Neoadjuvant chemotherapy
title Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_full Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_fullStr Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_full_unstemmed Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_short Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_sort small cell neuroendocrine tumor of the bladder a rare disease in a low risk woman
topic Bladder cancer
Neuroendocrine tumor
Oncology
Neoadjuvant chemotherapy
url http://www.sciencedirect.com/science/article/pii/S2214442021003636
work_keys_str_mv AT jordansarver smallcellneuroendocrinetumorofthebladderararediseaseinalowriskwoman
AT markmemo smallcellneuroendocrinetumorofthebladderararediseaseinalowriskwoman